Copertina

Daptomycin Dose Optimization in Pediatric Staphylococcus aureus Bacteremia: A Pharmacokinetic/Pharmacodynamic Investigation

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Katie B. Olney, Joel I. Howard, David S. Burgess
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	The Journal of Clinical Pharmacology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Physiologically Based Pharmacokinetic/Pharmacodynamic Model for Secukinumab: Dose Exploration in Pediatric Patients with Plaque Psoriasis
di: Liu Zhiwei, et al.
Pubblicazione: (2025)

Indomethacin Pharmacokinetics and Pharmacodynamics in Pregnancies With Preterm Labor: The Need for Dose‐Ranging Trials
di: Stephen J. Balevic, et al.
Pubblicazione: (2024)

A Randomized, Parallel, Open‐Label, Single‐Dose and Multiple‐Dose Clinical Trial to Investigate the Pharmacokinetic, Pharmacodynamic, and Safety Profiles of Obicetrapib in Healthy Participants in China
di: Jing Zhang, et al.
Pubblicazione: (2024)

Dose Optimization of BIIB107, an Anti‐Alpha‐4 Integrin Monoclonal Antibody, Through Population Pharmacokinetic and Pharmacodynamic Modeling
di: Marie Toukam, et al.
Pubblicazione: (2025)

Pharmacokinetics‐Based Pediatric Dose Evaluation and Optimization Using Saliva – A Case Study
di: Marion Anliker‐Ort, et al.
Pubblicazione: (2024)

Population Pharmacokinetics and Dosing Simulations of Pentobarbital in the Pediatric Population
di: Victoria Etges Helfer, et al.
Pubblicazione: (2026)

Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous and Intravenous Garadacimab Following Single‐Dose Administration in Healthy Japanese and White Adults
di: Fiona Glassman, et al.
Pubblicazione: (2024)

Population Pharmacokinetics (PopPK) Support for Pediatric Dosing of Biological Products
di: Brianna Eales, et al.
Pubblicazione: (2024)

Physiologically based Pharmacokinetic/Pharmacodynamic Modeling (PBPK/PD) of Famotidine in Pregnancy
di: Xiaomei I. Liu, et al.
Pubblicazione: (2025)

Physiologically Based Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Analysis for Ceftriaxone Dosing in Pregnant Women: Model Development and Clinical Applications
di: Xinyue Chen, et al.
Pubblicazione: (2026)

Guiding Dyslipidemia Treatment: A Population Pharmacokinetic–Pharmacodynamic Framework for Obicetrapib
di: Allison Dunn, et al.
Pubblicazione: (2024)

A Phase I Study of the Pharmacokinetics, Pharmacodynamics, and Safety of Liposomal Bupivacaine for Sciatic Nerve Block in the Popliteal Fossa for Bunionectomy
di: Daniel I. Sessler, et al.
Pubblicazione: (2024)

Safety, Pharmacokinetics, and Pharmacodynamics of the New Aldose Reductase Inhibitor Govorestat (AT‐007) After a Single and Multiple Doses in Participants in a Phase 1/2 Study
di: Riccardo Perfetti, et al.
Pubblicazione: (2024)

Crossing the Chasm: How to Approach Translational Pharmacokinetic–Pharmacodynamic Modeling of Phage Dosing
di: Gauri G. Rao, et al.
Pubblicazione: (2024)

Pharmacokinetic and Pharmacodynamic Modeling Analysis of Delpazolid (LCB01‐0371) in Adult Patients with Pulmonary Tuberculosis
di: Sang Min Lee, et al.
Pubblicazione: (2024)

Pharmacokinetic, Pharmacodynamic, and Safety Profiles of Proline Henagliflozin in Chinese Subjects with Varying Degrees of Liver Dysfunction
di: Likun Ding, et al.
Pubblicazione: (2024)

Population Pharmacokinetics and Loading Dose Optimization of Intravenous Valproic Acid in Hospitalized Thai Patients
di: Sirima Sitaruno, et al.
Pubblicazione: (2024)

Population Pharmacokinetics and Dosing Optimization of Piperacillin in Elderly Patients with Pneumonia in the Intensive Care Unit
di: Jing Sun, et al.
Pubblicazione: (2025)

Comparing the Efficacy of Various Insulin Types: Pharmacokinetic and Pharmacodynamic Modeling of Glucose Clamp Effects in Healthy Volunteers
di: Yi Chien Chang, et al.
Pubblicazione: (2025)

Effect of Hepatic Impairment on the Pharmacokinetics and Pharmacodynamics of SHR4640, a Selective Human Urate Transporter 1 Inhibitor
di: Xiaotong Hu, et al.
Pubblicazione: (2024)

Dried Blood Spots Sampling and Population Pharmacokinetic Modeling for Dosing Optimization of Piperacillin in Chinese Neonates
di: Pei Li, et al.
Pubblicazione: (2024)

Optimizing Linezolid Dosing in Lung Transplant Recipients: Population Pharmacokinetics, Target Attainment, and Thrombocytopenia Risk Assessment
di: Dan Zhang, et al.
Pubblicazione: (2026)

Population Pharmacokinetics to Support Intravenous and Enteral Methadone Dosing in Children
di: Kevin M. Watt, et al.
Pubblicazione: (2025)

Safety, Pharmacokinetics, and Pharmacodynamics of Etrasimod: Single and Multiple Ascending Dose Studies in Healthy Adults
di: Caroline A. Lee, et al.
Pubblicazione: (2024)

Physiologically Based Pharmacokinetic Modeling to Predict Maternal Pharmacokinetic Changes of Topiramate During Pregnancy and Recommend Dose Adjustments
di: Yuying Chen, et al.
Pubblicazione: (2025)

Population Pharmacokinetic Simulations for Dose Optimization of Tenofovir Disoproxil Fumarate in HIV‐Infected Patients with Moderate‐to‐Severe Renal Impairment
di: Apinya Boonpeng, et al.
Pubblicazione: (2024)

Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Studies Related to Vincristine‐Induced Peripheral Neuropathy in Chinese Pediatric ALL Patients
di: Yawen Yuan, et al.
Pubblicazione: (2024)

Randomized, Placebo‐Controlled, First‐in‐Human Study of the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Oral Doses of Novel Antitubercular Drug Candidate, GSK2556286, in Healthy Adults
di: Emma Ilsley, et al.
Pubblicazione: (2026)

Physiologically Based Pharmacokinetic Modeling of Lemborexant: Exploration of Doses for Populations with Hepatic Impairment
di: Wanhong Wu, et al.
Pubblicazione: (2025)

Physiologically Based Pharmacokinetic Modeling of Lurasidone, an Antipsychotic Drug: Impact of CYP3A4 Polymorphisms and Hepatic Impairment on Exposure and Dose Optimization
di: Seung‐Hyun Jeong, et al.
Pubblicazione: (2026)

Population Pharmacokinetics of Caffeine in Infants with Hypoxic‐Ischemic Encephalopathy: A Phase I, Dose‐Escalating Trial
di: Elizabeth J Thompson, et al.
Pubblicazione: (2025)

Evaluating Tranexamic Acid Dosing Strategies for Postpartum Hemorrhage: A Population Pharmacokinetic Approach in Pregnant Individuals
di: Allison Dunn, et al.
Pubblicazione: (2025)

Dose Ranging in Pediatric Drug Development Trials Submitted to the US FDA 2012–2020
di: Carlton K. K. Lee, et al.
Pubblicazione: (2025)

Characterizing the Nonlinear Pharmacokinetics and Pharmacodynamics of BI 187004, an 11β‐Hydroxysteroid Dehydrogenase Type 1 Inhibitor, in Humans by a Target‐Mediated Drug Disposition Model
di: Xuanzhen Yuan, et al.
Pubblicazione: (2024)

External Evaluation of Population Pharmacokinetic Models for High‐Dose Methotrexate in Adult Patients with Hematological Tumors
di: Shengyang Chen, et al.
Pubblicazione: (2024)

Pooled Population Pharmacokinetic Analysis and Dose Recommendations for Ciprofloxacin in Intensive Care Unit Patients with Obesity
di: Koen P. van Rhee, et al.
Pubblicazione: (2024)

Physiologically Based Pharmacokinetic Modeling of Caffeine in Preterm Neonates: Influence of Renal Function and Impairment on Dosing
di: Nolan Thomas, et al.
Pubblicazione: (2025)

Clinical Impact of Hepatic Impairment on the Pharmacokinetics of Sotorasib and Its Major Metabolites: Implications for Dose Adjustment
di: Mason McComb, et al.
Pubblicazione: (2025)

A Phase 1, Open‐Label, Single Ascending (Two Levels) Dose Study to Evaluate the Pharmacokinetics of Vorasidenib in Healthy Japanese and Non‐Asian Participants
di: Tharin Limsakun, et al.
Pubblicazione: (2026)

Prediction of Pediatric Pharmacokinetics for CYP3A4 Metabolized Drugs: Comparison of the Performance of Two Hepatic Ontogeny Within a Physiologically Based Pharmacokinetic Model
di: Marc Codaccioni, et al.
Pubblicazione: (2024)